The price of Day One Biopharmaceuticals Inc (NASDAQ: DAWN) closed at $13.93 in the last session, down -3.20% from day before closing price of $14.39. On the day, 535869 shares were traded.
Ratios:
We take a closer look at DAWN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 12.72 and its Current Ratio is at 12.72. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on April 25, 2023, Downgraded its rating to Underperform and sets its target price to $9 from $34 previously.
On February 08, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $40.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 11 ’24 when Blackman Samuel C. sold 30,000 shares for $15.24 per share. The transaction valued at 457,314 led to the insider holds 1,194,662 shares of the business.
Blackman Samuel C. sold 20,000 shares of DAWN for $322,166 on Feb 27 ’24. The HEAD OF R&D now owns 1,224,662 shares after completing the transaction at $16.11 per share. On Feb 16 ’24, another insider, Bender Jeremy, who serves as the CHIEF EXECUTIVE OFFICER of the company, sold 7,615 shares for $15.25 each. As a result, the insider received 116,114 and left with 721,813 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DAWN now has a Market Capitalization of 1.22B and an Enterprise Value of 851.33M.
Stock Price History:
Over the past 52 weeks, DAWN has reached a high of $19.03, while it has fallen to a 52-week low of $9.67. The 50-Day Moving Average of the stock is 14.96, while the 200-Day Moving Average is calculated to be 13.26.
Shares Statistics:
According to the various share statistics, DAWN traded on average about 556.80K shares per day over the past 3-months and 957.69k shares per day over the past 10 days. A total of 87.23M shares are outstanding, with a floating share count of 58.93M. Insiders hold about 32.57% of the company’s shares, while institutions hold 76.21% stake in the company. Shares short for DAWN as of Feb 29, 2024 were 9.7M with a Short Ratio of 17.43, compared to 9.15M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 11.10% and a Short% of Float of 17.52%.
Earnings Estimates
The company has 7 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.66 for the current quarter, with a high estimate of -$0.63 and a low estimate of -$0.71, while EPS last year was -$0.59. The consensus estimate for the next quarter is -$0.67, with high estimates of -$0.56 and low estimates of -$0.79.
Analysts are recommending an EPS of between -$2.27 and -$2.89 for the fiscal current year, implying an average EPS of -$2.62. EPS for the following year is -$2.01, with 9 analysts recommending between -$1.21 and -$2.78.
Revenue Estimates
Based on 10 analysts’ estimates, the company’s revenue will be $74.32M in the next fiscal year. The high estimate is $148.9M and the low estimate is $15.1M. The average revenue growth estimate for next year is up 468.60% from the average revenue estimate for this year.
